Cargando…

Commentary: Data and COVID-19-associated mucormycosis: Time to pause and reassess?

Detalles Bibliográficos
Autor principal:	Nair, Akshay Gopinathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114616/ https://www.ncbi.nlm.nih.gov/pubmed/35225565 http://dx.doi.org/10.4103/ijo.IJO_14_22

Ejemplares similares

Commentary: COVID-19-associated mucormycosis: The ongoing battle
por: Nair, Akshay Gopinathan
Publicado: (2021)

Commentary: Ocular myasthenia gravis: Interpreting the investigations
por: Nair, Akshay Gopinathan
Publicado: (2022)

Commentary: Combating COVID-19-associated mucormycosis with limited resources
por: Kim, Usha, et al.
Publicado: (2022)

COVID-19 management: Opportunity to reassess protocols?
por: Sodhi, Jitender, et al.
Publicado: (2022)

Fostering a deeper understanding of COVID-19-associated mucormycosis – A commentary on “The mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum” (Int. J. Surg. 2021:106031)
por: MohanaSundaram, ArunSundar, et al.
Publicado: (2021)

Commentary: Pneumonectomy for resection of pulmonary mucormycosis: Enough is never too much
por: Merritt, Robert E.
Publicado: (2021)

Commentary: Gift of life in the time of COVID-19
por: Hsin, Michael, et al.
Publicado: (2022)

Commentary: Lung surgery in the time of COVID-19
por: Muñoz-Largacha, Juan A., et al.
Publicado: (2020)

Diabetes, COVID-19 and Mucormycosis: Unanswered Questions!
por: Rastogi, Ashu, et al.
Publicado: (2021)

The Pathogenetic Dilemma of Post-COVID-19 Mucormycosis in India
por: Chakrabarti, Sankha Shubhra, et al.
Publicado: (2022)

Commentary: Training in the time of coronavirus disease 2019 (COVID-19)
por: Tibayan, Frederick A.
Publicado: (2021)

Commentary: Obesity in the time of coronavirus disease 2019 (COVID-19)
por: Shah, Ashish S.
Publicado: (2021)

COVID-19 and the alarming rise of “black fungus” (mucormycosis) infection
por: Khajotia, Rumi
Publicado: (2022)

Tracking global resources and capacity for health research: time to reassess strategies and investment decisions
por: Adam, Taghreed, et al.
Publicado: (2023)

Commentary: "Indovation" in retinopathy of prematurity management during COVID-19 times
por: Singh, Simar Rajan, et al.
Publicado: (2021)

Elongation Factor P Interactions with the Ribosome Are Independent of Pausing
por: Tollerson, Rodney, et al.
Publicado: (2017)

Let’s talk about mucormycosis emergency with COVID-19: Invest in future
por: Malik, Kamlesh, et al.
Publicado: (2022)

Reassessing the role of NAD as a prosurvival factor
por: Preyat, Nicolas, et al.
Publicado: (2015)

Embryoid research calls for reassessment of legal regulations
por: Hengstschläger, Markus, et al.
Publicado: (2021)

Reassessing assumptions about the evolution of herbivore teeth
por: Sanson, Gordon D.
Publicado: (2023)

Commentary: COVID-19 and diabetes
por: Villabona, Carmen V.
Publicado: (2020)

Commentary - Should immediate sequential bilateral cataract surgery be the norm in the COVID-19 era?
por: Nair, Sridevi, et al.
Publicado: (2021)

Time to reflect: How has COVID‐19 transformed you? A commentary
por: Jansen, Renée S.
Publicado: (2022)

Commentary: The importance of operative timing in the era of coronavirus disease 2019 (COVID-19)
por: Costello, John P., et al.
Publicado: (2021)

Commentary on “Mucormycosis co-infection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum” (Int J Surg 2021, 92:106031) – A pulmonary perspective
por: Gangakhedkar, Mihir R, et al.
Publicado: (2021)

Magnetic resonance imaging in rhino-orbital-cerebral mucormycosis
por: Sreshta, Kanduri, et al.
Publicado: (2021)

Time to pause, to think, and to recalibrate after COVID-19
por: Pal Singh Gambhir, Raghvinder
Publicado: (2020)

Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study
por: Dave, Tarjani Vivek, et al.
Publicado: (2021)

Hot Topic Commentary on COVID-19
por: Kong, Ah-Ng, et al.
Publicado: (2020)

Emerging Pathogenic Respiratory Mycoplasma hominis Infections in Lung Transplant Patients: Time to Reassesses it's Role as a Pathogen?
por: Spiller, Owen B.
Publicado: (2017)

Mucormycosis as a complication of Covid-19 – A case report
por: Raghu, Dr. Roshini, et al.
Publicado: (2021)

Commentary on CDC data showing an increased risk for pediatric diabetes with COVID‐19 infection
por: Gujral, Jasmine, et al.
Publicado: (2022)

Commentary: Corneal neurotization
por: Nair, Sridevi, et al.
Publicado: (2022)

Commentary: Timing of therapeutic keratoplasty
por: Prajna, N Venkatesh, et al.
Publicado: (2019)

Commentary: Take your time!
por: Miceli, Antonio
Publicado: (2021)

Commentary: Are these times still unprecedented?
por: Chen, Jonathan M.
Publicado: (2021)

Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum
por: Devnath, Popy, et al.
Publicado: (2021)

Periprocedural anticoagulation in non-ST-segment elevation acute coronary syndrome: time to reassess?
por: Chandiramani, Rishi, et al.
Publicado: (2020)

Commentary: COVID-19: “There is no education like adversity”
por: Stephens, Elizabeth H.
Publicado: (2020)

COVID-19 and Fertility in Canada: a Commentary
por: Fostik, Ana
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ggg66f63jbd6fh0kkln0qgu5c5